2023 Speakers

2023 Speakers - 6th Annual TPD Summit

Discover what fresh new expert speakers and returning KOLs presented at the 6th Annual Targeted Protein Degradation Summit in  October 2023.

Agnieszka Konpacka

Scientific Leader Protein Degradation Group

GlaxoSmithKline

Ai Yamamoto

Assistant Professor

Columbia University

Alex Campos

Senior Director Proteomics Platform

Plexium

Angela Cacace

Senior Vice President, Neuroscience

Arvinas

Anna Bunin

Director, Discovery and Translational Biology

Biohaven Pharmaceuticals

Ashok Dongre

Director & Head of Proteomics

Bristol-Myers Squibb

Atul Tiwari

Head Discovery Service Solutions Biology

Syngene

Beth Hoffman

Chief Executive Officer

Origami Therapeutics

Bradlee Heckmann

Co-Founder & Chief Scientific Officer

Asha Therapeutics

Breanna Zerfas

Senior Scientist, Group Leader Biochemistry and Molecular Biology

The Center for Protein Degradation at the Dana-Farber Cancer Institute

Byron DeLabarre

Chief Technology Officer

Pin Therapeutics

Charu Chaudhry

Senior Principal Scientist

Janssen

Christian Dillon

Chief Scientific Officer

PhoreMost

Chunhai (Charlie) Hao

Bicentennial Chair and Professor

Indiana University School of Medicine

Dalia Barsyte-Lovejoy

Principal Investigator

Structural Genomics Consortium, University of Toronto

Danette Daniels

Vice President Protein Degradation Platform

Foghorn Therapeutics

Débora Bonenfant

Vice President, Proteomics

Monte Rosa Therapeutics

Dengfeng Dou

Vice President, Lead Generation Unit

Hitgen

Dmitri Ivanov

Associate Professor

UT Health San Antonio

Dong Seok Kim

Chief Executive Officer

Aevis Bio

Dongwen Lyu

Assistant Professor & Associate Director

UT Health San Antonio

Eddine Saiah

Chief Scientific Officer

Stablix

Eric Wegrzyniak

Director Chemistry Automation

Nurix Therapeutics

Erik Jonsson

Senior Scientist

Bristol Myers Squibb

Feng Wang

Senior Principal Scientist & Lab Head of Protein Homeostasis

Pfizer

Fleur Ferguson

Assistant Professor

University of California, San Diego

Frances Rodriguez-Rivera

Director

Covant Therapeutics

Gael Nicholas

Senior Technical Sales Specialist

Refeyn

Giovanni Spagnolli

Chief Technology Officer

Sibylla Biotech

Guangdi Wang

Founder & Chief Executive Officer

Endotarget

Guillaume Tremintin

Senior Marketing Manager

Bruker

Gwenn Hansen

Chief Scientific Officer

Nurix Therapeutics

Hailong Zhang

Chief Executive Officer

Blueray Biopharma

Hannah Maple

Innovation Manager

BioTechne

Heide Düvel

DMPK Expert Targeted Protein Degradation

EMD Serono

Henrik Daub

Chief Scientific Officer

NEOsphere Biotechnologies GmbH

Huan Rui

Associate Director

Kestrel Therapeutics

Hugo Gagnon Ph.D.

Chief Scientific Officer

Allumiqs

Ingo V. Hartung

Head of Medicinal Chemistry & Drug Design

EMD Serono

Jason Wiles

Vice President, Discovery and Preclinical Sciences

Avilar Therapeutics

Jeff Bagdanoff

Senior Principal Scientist

Novartis

Jennifer Johnston

Co-Founder & Chief Executive Officer

NysnoBio

Jesus Medina

Senior Director

Arvinas

Jo Lim

Associate Director - Immunology

Orum Therapeutics

Joe Pariseau

Director, Clinical Development Sciences

C4 Therapeutics

John Castle

Chief Data Scientist

Monte Rosa Therapeutics

Jorge Lozano-Juste

Group Leader

Instituto de Biologia Molecular y Celular de Plantas (IBMCP)

Jose C. Clemente

Senior Director of Biology

Proteovant Therapeutics

Kaitlyn Lovato

Scientist

Janssen Pharmaceuticals

Kara West

Head of US Sales

PreOmics

Karteek Kadimisetty

Director R&D

Lifesensors

Katherine Donovan

Lead Scientist

Dana Farber Cancer Institute

Katie Spooner

Research Analyst

Beacon

Katya Marjon

Director Tumor Biology

Pfizer

Kerry Benenato

Chief Scientific Officer

76Bio

Kevin Woller

Senior Principal Research Scientist

AbbVie

Koichi Ito

Director Biology

Prelude Therapeutics

Kristin Riching

Senior Research Scientist

Promega

Kyung-Soo Inn

Founder & Chief Executive Officer

Prazer Therapeutics

Laura La Bonte

Senior Director, Biology & Research Portfolio Strategy

Foghorn Therapeutics

Leah Fung

Chief Executive Officer

Biotheryx

Levi Smith

Senior Analyst

Samsara BioCapital

Lucilia Mouriès

Senior Scientific Program Manager, TPD Safety

Health & Environmental Sciences Institute (HESI)

Luiz Miguel Camargo

Chief Scientific Officer

UbiquiTx, Inc.

Marcel Rieker

Project Lead

EMD Serono

Maria Soloveychik

Chief Executive Officer

SyntheX

Mark Niosi

Principal Scientist

Pfizer

Mary Mader

Vice President Molecular Innovation

Indiana Biosciences Research Institute

Masahiko Hayakawa

Vice President, Head of Targeted Protein Degradation

Astellas Pharma Inc.

Matt Clarke

CEO

X-Chem

Matt Disney

Chair Department of Chemistry

The Scripps Research Institute, Florida

Matt Sowa

Vice President Lead Discovery

C4 Therapeutics

Matthew Calabrese

Senior Director, Head of Structural & Molecular Sciences

Pfizer

Matthew O’Brien Laramy

Principal Scientist

Genentech

Matthias Brand

Co-Founder & Chief Scientific Officer

Proxygen

Michael Dabrowski

Chief Executive Officer

Pelago Bioscience AB

Miklós Békés

Associate Professor

Arvinas

Nan Ji

Chief Executive Officer

PAQ Therapeutics

Naresh Jain

President & Chief Executive Officer

NJ Bio

Owen Wallace

Chief Scientific Officer

Monte Rosa Therapeutics

Patrick Foster

Vice President CMC

C4 Therapeutics

Patrick Gunning

Chief Scientific Officer

Dunad Therapeutics

Paul Tempest

Head of Medicinal Chemistry

Aprinoia Therapeutics

Pawel Dobrzanski

Vice President, Biology

Captor Therapeutics

Priscilla Yang

Professor

Stanford University School of Medicine

Qi Hao

Associate Director of Protein Sciences

Calico Labs

Raghd Rostom

Associate Partner

Syncona Investment Management Limited

Randolph Lopez

Chief Technology Officer

A-Alpha Bio

Riccardo Sabatini

Chief Data Scientist

Orionis Biosciences

Richard Miller

Executive Director, Lead Discovery

Kymera Therapeutics

Rohan Beckwith

Vice President Chemistry

Neomorph Inc

Ruo Xu

Vice President Chemistry

Kintor Pharmaceuticals

Sam Gattis

Head of R&D

Oerth Bio

Scott Foster

Principal Scientist

Genentech

Segolene Martin

Chief Executive Officer

Kantify

Shaomeng Wang

Warner-Lambert/ParkeDavis Professor in Medicine & Professor

University of Michigan

Shourjo Ghose

Business Development Manager

Bruker

Shyra Gardai

Chief Scientific Officer

EpiBiologics

Simon Bailey

Executive Vice President, Drug Discovery

Plexium

Stefanus Steyn

Research Fellow

Pfizer

Stephanie Leuenroth-Quinn

Pharmacologist

US Food & Drug Adminstration

Steve Bellon

Chief Scientific Officer

Foghorn Therapeutics

Steven Richards

Vice President Chemistry

Ambagon Therapeutics

Steven Sparks

Senior Research Fellow

Arvinas

Sule Karaman

Associate Director Preclinical Safety

Novartis – NIBR/ Novartis Institutes for Biomedical Research

Swetha Murali

Senior Associate

OMX Ventures

Toshitake Kobayashi

Vice President, Chemistry

FIMECS

Vijay Sabesan

Senior Vice President, Technical Operations & Quality, CMC

Kymera Therapeutics

Vincenzo D’Angiolella

Assistant Professor

University of Oxford

Wu Du

Senior Vice President

Hinova Pharmaceuticals Inc.

Yael David

Associate Member

Memorial Sloan Kettering Center

Yang Xie

Senior Vice President Oncology

neoX Biotech

Ying Zhang

Senior Scientist

UCB Biosciences

Yong Cang

Chief Scientific Officer & Professor

Degron Therapeutics & ShanghaiTech University

Yong Tae Kwon

Professor & Chief Executive Officer

Seoul National University & AUTOTAC Bio Inc.

Yue Xiong

Chief Scientific Officer

Cullgen

Yuehan Feng

Senior Director Proteomics Application

Biognosys

Yufei Xu

Senior Director

Triana Biomedicines

Zoran Rankovic

Director, Chemistry Centers

St. Jude Children’s Research Hospital